摘要
本文介绍了我国药品研发的现状,分析了我国药品研发存在的主要问题,并针对存在的主要问题提出了一点建议。当今,我国医药行业及药品研发机遇与挑战并存,我们要勇抓机遇,直面挑战,做出保质保量的良药。
This paper introduces the current situation of drug research and development in China,analyzes the main problems existing in drug research and development in China,and puts forward some suggestions for the main problems.Nowadays,opportunities and challenges coexist in China's pharmaceutical industry and drug research and development.We should seize the opportunities,face the challenges and make quality and quantity guaranteed medicines.
作者
郑丽
杨灿
杨玉军
王允雨
于伟东
樊丽娜
史乾
郝继成
Zheng Li;Yang Can;Yang Yujun;Wang Yunyu;Yu Weidong;Fan Lina;Shi Qian;Hao Jicheng(Heze City Development Investment Co.,Ltd,Heze 274000,China;Shandong Danhong Pharmaceutical Co.,Ltd.,Heze 274000,China;Shandong Buchang Pharmaceutical Co.,Ltd.,Heze 274000,China;Shandong Kangai Pharmaceutical Co.,Ltd.,Heze 274000,China)
出处
《山东化工》
CAS
2020年第19期254-255,共2页
Shandong Chemical Industry
关键词
药品研发
知识产权
风险识别
drug research and development
intellectual property right
risk identification
